595 related articles for article (PubMed ID: 22841766)
1. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.
Bork K; Hardt J; Witzke G
J Allergy Clin Immunol; 2012 Sep; 130(3):692-7. PubMed ID: 22841766
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
3. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
[TBL] [Abstract][Full Text] [Related]
4. Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.
Bork K; Davis-Lorton M
Eur Ann Allergy Clin Immunol; 2013 Feb; 45(1):7-16. PubMed ID: 23678554
[TBL] [Abstract][Full Text] [Related]
5. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
6. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
8. C1 inhibitor concentrate treatment of multiple laryngeal attacks in a 53-year-old woman with hereditary angioedema.
Packer FR
Immunotherapy; 2013 Aug; 5(8):855-7. PubMed ID: 23647478
[TBL] [Abstract][Full Text] [Related]
9. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
[TBL] [Abstract][Full Text] [Related]
10. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
Moellman JJ; Bernstein JA
J Emerg Med; 2012 Aug; 43(2):391-400. PubMed ID: 22285754
[TBL] [Abstract][Full Text] [Related]
12. Asphyxiation by laryngeal edema in patients with hereditary angioedema.
Bork K; Siedlecki K; Bosch S; Schopf RE; Kreuz W
Mayo Clin Proc; 2000 Apr; 75(4):349-54. PubMed ID: 10761488
[TBL] [Abstract][Full Text] [Related]
13. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
[TBL] [Abstract][Full Text] [Related]
14. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.
Jurado-Palomo J; Muñoz-Caro JM; López-Serrano MC; Prior N; Cabañas R; Pedrosa M; Burgueño M; Caballero T
J Investig Allergol Clin Immunol; 2013; 23(1):1-6. PubMed ID: 23653967
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.
Kajdácsi E; Jani PK; Csuka D; Varga LÁ; Prohászka Z; Farkas H; Cervenak L
J Allergy Clin Immunol; 2014 Jun; 133(6):1686-91. PubMed ID: 24522092
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
Bork K; Bernstein JA; Machnig T; Craig TJ
J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis and management of hereditary angioedema in a Greek family.
Papadopoulou-Alataki E; Foerster T; Antari V; Pavlitou-Tsiontsi A; Varlamis G
Int Arch Allergy Immunol; 2008; 147(2):166-70. PubMed ID: 18535392
[TBL] [Abstract][Full Text] [Related]
18. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
19. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
[TBL] [Abstract][Full Text] [Related]
20. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
Tallroth GA
Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
